Five shots of Goldschläger, four strong and frothy piña coladas, three carafes of grenache, two 40-ounce bottles of Colt 45 ...

Krystal, the original home of the slider in the South, is serving up more ways to satisfy cravings with the launch of all-new ...

Arizona State Retirement System boosted its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 8.5% in the 4th ...

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the ...

CITRUS COUNTY, Fla. — A 50-year-old mother and Lecanto Middle School teacher was killed and her three young children were ...

Jefferies has initiated Krystal Biotech at buy citing growth in sales of Vyjuvek (beremagene geperpavec), a gene therapy for ...

Shares of Krystal Biotech KRYS have gained 15.8% in the past month compared with the industry’s growth of 4%. The stock has also outperformed the industry and the sector in this timeframe.

KRYS stock surges 15% in a month on strong uptake of Vyjuvek and encouraging pipeline progress. We are optimistic about the stock as we believe there is room for further growth.